Ye F, Bian L, Wen J, Yu P, et al. Additional capecitabine use in early-stage triple negative breast cancer patients receiving standard chemotherapy: a new era? A meta-analysis of randomized controlled trials. BMC Cancer 2022;22:261.
PMID: 35279130